LightPath Technologies, Inc. — Form 10-Q Summary
Business context and reporting period
Reports the unaudited fiscal first quarter ended September 30, 2012, compared with the quarter ended September 30, 2011. LightPath manufactures precision molded optical components and assemblies for industrial, medical, defense, test and measurement, and telecommunications markets, with operations in the United States and China.
Financial results and liquidity
- Revenue: $2.891 million, up 6% year over year. Higher custom optics, including Raytheon work, and industrial tool sales were partly offset by lower collimator and GRADIUM sales.
- Gross margin: $1.177 million, or approximately 41% of revenue, versus $1.083 million, or approximately 40%, a year earlier.
- Operating result and earnings: Operating loss was $26,519, compared with a $208,933 loss. Net income was $101,221, or $0.01 per basic and diluted share, versus a net loss of $198,447, or $0.02 per share.
- Cash flow: Operating activities used $21,026, compared with providing $117,349 in the prior-year quarter. Capital expenditures were $171,069; cash declined $192,358 to $2.162 million.
- Balance sheet and liquidity: Total assets were $8.442 million and stockholders’ equity was $4.252 million. Current assets were $6.461 million and current liabilities $2.860 million. Management reported cash of approximately $2.0 million on November 5, 2012.
- Debt: $1.0875 million of 8% convertible debentures was outstanding at September 30, including $1.0125 million owed to related parties. The debentures are secured and due August 1, 2013; dividends are prohibited while they remain outstanding.
- Other metrics: Management-reported EBITDA was $341,164 versus $71,211. Inventory was $1.601 million; days cost of sales in inventory was 85 versus 100. Days sales outstanding was 66 versus 69.
Material changes versus the prior comparable period
- Revenue increased approximately 6%, and precision molded optics unit shipments rose 25%. Gross margin improved by about one percentage point.
- SG&A declined approximately $14,000 to $982,455; new product development expense declined 26% to $212,457.
- The earnings improvement included a $95,784 gain from remeasuring June 2012 warrant liabilities and $50,000 of GRADIUM license income. These items, along with increased sales and lower development costs, contributed to the year-over-year improvement.
- Cash from operations weakened to a $21,026 use, primarily reflecting higher other receivables associated with the Raytheon purchase order. Investing cash outflow was lower than in the prior-year quarter.
Outlook, commentary, risks and unusual items
- Management expects modest revenue increases during the rest of fiscal 2013 and anticipates improved operating cash flow, citing order bookings, quote activity and a 12-month backlog of $5.46 million, up approximately $1.26 million from June 30, 2012.
- Management’s plan anticipates growth in infrared lenses and precision molded optics, alongside cost-reduction efforts. It expects new product development spending to increase modestly as infrared products are developed.
- Management cautions that cash flow and cash management remain concerns. The company has a history of operating losses and a substantial accumulated deficit. It may need external debt or equity financing, but has no committed financing or current borrowing availability; financing may not be available on acceptable terms.
- Identified risks include weaker sales or collections, higher material or labor costs, failure to achieve planned production efficiencies, economic conditions, and increased discretionary spending. Management notes that strategic alternatives could be considered if financing or cash generation proves insufficient.
- A $1.1 million Raytheon development order supports a defense thermal-imaging program. Through September 30, LightPath had recognized $869,000 of revenue against $643,500 invoiced, recording the $225,500 difference as other receivables. Completion was expected by July 2013.
- In June 2012, LightPath raised approximately $1.983 million gross through a private stock placement and issued warrants. Because of exercise-price adjustment provisions, those warrants are recorded as a liability; their $95,784 quarterly fair-value decrease produced a gain, and the liability stood at $991,512 at quarter-end.
- In September, the company licensed GRADIUM intellectual property exclusively to Hubei New Hua Guang for an initial five-year term. The agreement provides $150,000 in licensing fees and royalties beginning in year four; only the first $50,000 milestone was recognized in this quarter.
- Management concluded disclosure controls were effective as of September 30, 2012; no material change in internal control over financial reporting was reported during the quarter.
Investor verification priorities
- Track cash burn, collections, and whether operating cash flow improves as management expects; confirm the status of any financing plans.
- Review the August 2013 debenture maturity, related-party portion, and repayment or conversion terms.
- Verify progress, remaining costs, billings and collections on the Raytheon project, including the $225,500 receivable and expected July 2013 completion.
- Assess the sustainability of reported earnings by separating core operating performance from warrant remeasurement gains and license income.
- Monitor backlog conversion, customer concentration, product mix and progress shifting customers to lower-cost glass, which management says affects manufacturing and coating costs.
- Review potential dilution from outstanding warrants, convertible debentures and equity awards, and the valuation assumptions for the warrant liability.